Inventor
MARGUET FRANK
FR15 patents
⚠️ This page may combine multiple inventors who share the name “MARGUET FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI AVENTIS
7 patentsUS7109194B2Sep 19, 2006
3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use
SANOFI AVENTIS7 citations73
US7405306B2Jul 29, 2008
3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
SANOFI AVENTIS1 citations62
US7235554B2Jun 26, 2007
3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments
SANOFI AVENTIS2 citations62
US7569567B2Aug 4, 2009
3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use
SANOFI AVENTIS0 citations51
US7402682B2Jul 22, 2008
3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use
SANOFI AVENTIS0 citations51
US7323467B2Jan 29, 2008
3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
SANOFI AVENTIS0 citations51
US7547706B2Jun 16, 2009
1H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use
SANOFI AVENTIS1 citations47
SANOFI SA
5 patentsUS8835418B2Sep 16, 2014
Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
SANOFI SA12 citations80
US10988524B2Apr 27, 2021
Modified relaxin B chain peptides and their therapeutic use
SANOFI SA2 citations70
US10988523B2Apr 27, 2021
Modified lipidated Relaxin B chain peptides and their therapeutic use
SANOFI SA2 citations68
US8791119B2Jul 29, 2014
3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta
SANOFI SA2 citations54
US9233965B2Jan 12, 2016
3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta
SANOFI SA0 citations47
SANOFI SYNTHELABO
3 patentsUS6395729B1May 28, 2002
Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors
SANOFI SYNTHELABO26 citations90
US6262045B1Jul 17, 2001
4-Oxo-3,5-dihydro-4H-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy
SANOFI SYNTHELABO17 citations83
US6451795B1Sep 17, 2002
4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide derivatives, preparation and therapeutic use
SANOFI SYNTHELABO18 citations82